Logo
x

Search category

Subscribe Now

license Agreement

Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US

Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US

  • October 19, 2021
AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies

AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies

  • October 12, 2021
Bio-Thera Signs a License Agreement with Intract for Soteria and Phloral Technologies to Develop Oral Antibody Therapies

Bio-Thera Signs a License Agreement with Intract for Soteria and Phloral Technologies to Develop Oral Antibody Therapies

  • September 28, 2021
Innovent Signs a License Agreement with Union to Develop & Commercialize Orismilast for Inflammatory Dermatology Conditions in China

Innovent Signs a License Agreement with Union to Develop & Commercialize Orismilast for Inflammatory Dermatology Conditions in...

  • September 28, 2021
Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avastin (bevacizumab)

Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avasti...

  • September 9, 2021
Bio-Thera and Hikma Sign an Exclusive Commercialization and License Agreement for BAT2206 (biosimilar- ustekinumab) in the US

Bio-Thera and Hikma Sign an Exclusive Commercialization and License Agreement for BAT2206 (biosimilar- ustekinumab) in the US

  • August 30, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.